首页> 外文期刊>Hepato-gastroenterology. >Resection of hepatocellular carcinoma: the effect of surgical margin and blood transfusion on long-term survival. Analysis of 209 consecutive patients.
【24h】

Resection of hepatocellular carcinoma: the effect of surgical margin and blood transfusion on long-term survival. Analysis of 209 consecutive patients.

机译:肝细胞癌切除术:手术切缘和输血对长期生存的影响。连续分析209例患者。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND/AIMS: Certain prognostic factors affect the postoperative mortality and long-term survival of patients following hepatic resection for hepatocellular carcinoma (HCC) and may change the surgical strategy. METHODOLOGY: 209 consecutive patients underwent hepatic resection for HCC in our hospital. Seventy-three patients underwent major resection and 136 underwent minor resections. We looked for correlations between clinical, biological, surgical and pathological factors and postoperative mortality, disease-free survival and overall survival. RESULTS: The postoperative mortality rate was 7.7% (it fell to 0% in the last two years). The cumulative overall five-year survival rate was 27% and the overall disease-free survival rate was 7.3%. Multivariate analysis identified: (1) two independent prognostic factors for postoperative mortality: age and tumor size; (2) one risk factor for tumor recurrence: intraoperative blood transfusion, and (3) three independent prognostic factors for overall survival:infiltrative tumor type, surgical margin <10 mm and intraoperative blood transfusion. CONCLUSIONS: In addition to routine staging of the tumor, the preoperative evaluation of HCC patients should include tests to determine whether the tumor is infiltrative or expansive and whether it will be possible to obtain a surgical margin (>10 mm). This procedure should make it possible to propose an appropriate neoadjuvant treatment only to these patients. The prevention of intraoperative bleeding or blood transfusion should improve the disease-free and overall survival rates in HCC patients.
机译:背景/目的:某些预后因素会影响肝细胞癌(HCC)肝切除术后患者的术后死亡率和长期生存,并可能改变手术策略。方法:209例我院行肝切除术的肝癌患者。大手术73例,小手术136例。我们寻找临床,生物学,手术和病理因素与术后死亡率,无病生存期和总生存期之间的相关性。结果:术后死亡率为7.7%(最近两年降至0%)。五年累计总生存率为27%,无疾病总生存率为7.3%。多因素分析确定:(1)术后死亡率的两个独立预后因素:年龄和肿瘤大小; (2)肿瘤复发的一个危险因素:术中输血;(3)整体生存的三个独立预后因素:浸润性肿瘤类型,手术切缘<10 mm和术中输血。结论:除了常规的肿瘤分期外,对HCC患者的术前评估还应包括确定肿瘤是浸润性还是扩张性以及是否有可能获得手术切缘(> 10 mm)的测试。该程序应使仅对这些患者提出合适的新辅助治疗成为可能。预防术中出血或输血应提高HCC患者的无病生存率和总体生存率。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号